We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Marsh & McLennan Companies, Inc. (MRSH - Free Report) has delivered organic revenue growth above its long-term average for several years, helped by strong insurance brokerage activity, expanding consulting operations and acquisitions. However, global commercial insurance rates fell 5% in the first quarter, marking the seventh consecutive quarter of rate declines. The question investors are asking now is whether the organic growth momentum can continue as rates are normalizing.
The answer is likely yes, though growth will likely settle at a more sustainable pace rather than accelerate further. During the hard insurance market, rising premiums lifted brokerage commissions because Marsh earns a percentage of the premiums it places. As pricing across several commercial insurance lines becomes more balanced, that tailwind is expected to fade, making it harder to rely on premium inflation alone for growth.
Marsh will now need to lean on the strengths of its broader business. The company generates revenues from insurance brokerage, reinsurance, management consulting, and health, wealth and career consulting, giving it multiple avenues for growth. Strong client retention, new customer wins, higher insured exposures, cross-selling across its businesses, and continued expansion in specialty areas such as cyber and climate risk will become increasingly important.
Importantly, demand for risk advice continues to rise. Companies are navigating cyber threats, climate-related risks, supply-chain disruptions, geopolitical uncertainty and AI governance, creating opportunities for Marsh to deepen client relationships. Its broad service offering allows it to compete on expertise rather than pricing, helping offset a softer insurance market and supporting healthy organic growth over the long term.
How Are Marsh’s Peers Placed?
Peers, including Aon plc (AON - Free Report) and Arthur J. Gallagher & Co. (AJG - Free Report) , are increasingly relying on execution, specialization and market share gains.
Aon's growth strategy is centered on its "3x3 Plan," which focuses on integrating risk capital, health, wealth and human capital solutions. Organic growth has remained steady at 5% in the first quarter, despite softer pricing. Aon is increasingly emphasizing cross-selling, analytics and AI-enabled advisory services to drive growth. Gallagher remains one of the fastest-growing large brokers. Management expects roughly 6% organic growth in 2026, supported by strong new business production, high client retention, acquisitions and expansion in specialty lines such as reinsurance, retail brokerage and surety.
MRSH’s Price Performance, Valuation and Estimates
Shares of Marsh have declined 8.9% year to date compared with the industry’s fall of 16.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, Marsh trades at a forward price-to-earnings ratio of 15.64X, higher than the industry average but below its five-year median. MRSH currently carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Marsh’s 2026 earnings implies a 6.5% increase year over year.
View the Zacks #1 Rank List
Image: Shutterstock
Can Marsh Sustain Organic Growth as Pricing Tailwinds Ease?
Key Takeaways
Marsh & McLennan Companies, Inc. (MRSH - Free Report) has delivered organic revenue growth above its long-term average for several years, helped by strong insurance brokerage activity, expanding consulting operations and acquisitions. However, global commercial insurance rates fell 5% in the first quarter, marking the seventh consecutive quarter of rate declines. The question investors are asking now is whether the organic growth momentum can continue as rates are normalizing.
The answer is likely yes, though growth will likely settle at a more sustainable pace rather than accelerate further. During the hard insurance market, rising premiums lifted brokerage commissions because Marsh earns a percentage of the premiums it places. As pricing across several commercial insurance lines becomes more balanced, that tailwind is expected to fade, making it harder to rely on premium inflation alone for growth.
Marsh will now need to lean on the strengths of its broader business. The company generates revenues from insurance brokerage, reinsurance, management consulting, and health, wealth and career consulting, giving it multiple avenues for growth. Strong client retention, new customer wins, higher insured exposures, cross-selling across its businesses, and continued expansion in specialty areas such as cyber and climate risk will become increasingly important.
Importantly, demand for risk advice continues to rise. Companies are navigating cyber threats, climate-related risks, supply-chain disruptions, geopolitical uncertainty and AI governance, creating opportunities for Marsh to deepen client relationships. Its broad service offering allows it to compete on expertise rather than pricing, helping offset a softer insurance market and supporting healthy organic growth over the long term.
How Are Marsh’s Peers Placed?
Peers, including Aon plc (AON - Free Report) and Arthur J. Gallagher & Co. (AJG - Free Report) , are increasingly relying on execution, specialization and market share gains.
Aon's growth strategy is centered on its "3x3 Plan," which focuses on integrating risk capital, health, wealth and human capital solutions. Organic growth has remained steady at 5% in the first quarter, despite softer pricing. Aon is increasingly emphasizing cross-selling, analytics and AI-enabled advisory services to drive growth. Gallagher remains one of the fastest-growing large brokers. Management expects roughly 6% organic growth in 2026, supported by strong new business production, high client retention, acquisitions and expansion in specialty lines such as reinsurance, retail brokerage and surety.
MRSH’s Price Performance, Valuation and Estimates
Shares of Marsh have declined 8.9% year to date compared with the industry’s fall of 16.1%.
From a valuation standpoint, Marsh trades at a forward price-to-earnings ratio of 15.64X, higher than the industry average but below its five-year median. MRSH currently carries a Value Score of B.
The Zacks Consensus Estimate for Marsh’s 2026 earnings implies a 6.5% increase year over year.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.